More research topics identified under EU innovative medicines project
This article was originally published in SRA
The European Commission and the European pharmaceutical industry federation, EFPIA, have jointly identified a list of research topics aimed at accelerating the discovery and development of new medicines in the field of cancer, inflammatory and infectious diseases1,2.
You may also be interested in...
Drug companies will be able to “play around” with the new EU Clinical Trials Information System in a secure testing environment before it goes live in approximately 15 months.
The Canadian authorities have put in place an expedited pathway for authorizing new COVID-19 drugs and vaccines that offers a more agile approach to reviewing data than what was previously allowed.
A new pre-assessment service for COVID-19 clinical trials that was established by the UK medicines regulator to cut down on review times is being extended to a limited number of other kinds of trials.